Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
26.91
+0.04 (0.13%)
May 26, 2026, 2:53 PM EDT - Market open
Genmab Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 19, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $40 | Buy | Maintains | $40 | +48.67% | May 9, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $32 | Hold | Maintains | $32 | +18.94% | May 8, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $34 → $33 | Hold | Maintains | $34 → $33 | +22.65% | May 8, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $40 → $38 | Buy | Reiterates | $40 → $38 | +41.24% | Apr 30, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Upgrades $31 | Buy | Upgrades | $31 | +13.36% | Apr 22, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $32 | Buy | Initiates | $32 | +18.94% | Mar 26, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $48 | Buy | Reiterates | $48 | +78.41% | Feb 25, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.